| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |